Abbvie Inc (ABBV) - News Archive

Showing 4 of 4 results.

Navigating Uncertainties Investors Face Class Action Threats Amid Rising Operational Costs and Mixed Corporate Perfor...

In a pivotal moment for both Cerevel Therapeutics Holdings, Inc. and AbbVie Inc. a cloud of uncertainty has descended upon investors as they grapple with a growing class action lawsuit and escalating operational costs a...

May 2, 2025 • Major Pharmaceutical Preparations Industry Announcement Class ActionBetter Lowered Profit Outlook Outweigh

Analyzing AbbVie Inc.s Recent Performance and Market Dynamics A Comprehensive Overview

In the dynamic world of the pharmaceutical industry, companies face constant challenges and opportunities that can significantly impact their performance in the market. AbbVie Inc., a renowned pharmaceutical firm, has b...

Jul 3, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move Bollinger Lundbecks C Inc Christopher Raymond Morg

NIMML Institutes TITAN-X A.I.-Powered Precision Medicine Platform Proves Successful with Acquisition of Landos Biopharma by AbbVie

The NIMML Institute (NIMML), a renowned nonprofit institute dedicated to the discovery of innovative precision medicines for autoimmune diseases, is celebrating a significant milestone. Its co-founders, Dr. Josep Bassag...

Mar 25, 2024 • Major Pharmaceutical Preparations Industry Product Service News NYSE

Epcoritamab Shows Potential in Treating Refractory Follicular Lymphoma, as AbbVie Grapples with Rising Operational Costs Amid Slowing Revenues

COPENHAGEN, Denmark - New pivotal data introduced an innovative beacon of hope for patients dealing with hard-to-treat follicular lymphoma (FL). Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) announced promising resu...

Dec 9, 2023 Product Service News NYSE